Align Technology, Inc. (0HCK.L)
USD 221.79
(-3.78%)
USD 221.79
(-3.78%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 96.96 Million USD | -0.23% |
| 2022 | 126.9 Million USD | 1.22% |
| 2021 | 125.37 Million USD | 45.48% |
| 2020 | 86.18 Million USD | 45.57% |
| 2019 | 59.2 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 126.41 Million USD | -0.16% |
| 2024 Q3 | - USD | -68.29% |
| 2024 Q2 | 98.3 Million USD | -22.24% |
| 2023 Q2 | 133.41 Million USD | 5.24% |
| 2023 Q1 | 126.77 Million USD | -0.1% |
| 2023 FY | 126.61 Million USD | -0.23% |
| 2023 Q4 | 126.61 Million USD | -0.14% |
| 2023 Q3 | 126.8 Million USD | -4.96% |
| 2022 Q3 | 120.86 Million USD | -1.69% |
| 2022 Q2 | 122.94 Million USD | -5.59% |
| 2022 Q1 | 130.22 Million USD | 3.87% |
| 2022 FY | 126.9 Million USD | 1.22% |
| 2022 Q4 | 126.9 Million USD | 5.0% |
| 2021 Q1 | 63.84 Million USD | -0.93% |
| 2021 FY | 125.37 Million USD | 45.48% |
| 2021 Q4 | 125.37 Million USD | 29.89% |
| 2021 Q3 | 96.52 Million USD | -0.22% |
| 2021 Q2 | 96.73 Million USD | 51.51% |
| 2020 Q4 | 64.44 Million USD | -1.64% |
| 2020 Q1 | 53.74 Million USD | 23.66% |
| 2020 Q3 | 65.51 Million USD | 29.43% |
| 2020 Q2 | 50.61 Million USD | -5.82% |
| 2020 FY | 86.18 Million USD | 45.57% |
| 2019 Q1 | 59.3 Million USD | 0.0% |
| 2019 FY | 59.2 Million USD | 0.0% |
| 2019 Q4 | 43.46 Million USD | 0.23% |
| 2019 Q3 | 43.36 Million USD | -26.67% |
| 2019 Q2 | 59.14 Million USD | -0.28% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -709.213% |
| Accuray Incorporated | 172.15 Million USD | 43.674% |
| Elevance Health Inc. | 25.12 Billion USD | 99.614% |
| AxoGen, Inc. | 69.29 Million USD | -39.941% |
| Boston Scientific Corporation | 9.09 Billion USD | 98.934% |
| CVS Health Corporation | 79.38 Billion USD | 99.878% |
| Cardinal Health, Inc. | 5.6 Billion USD | 98.271% |
| Centene Corporation | 17.69 Billion USD | 99.452% |
| DaVita Inc. | 11.11 Billion USD | 99.128% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 99.768% |
| Hologic, Inc. | 2.53 Billion USD | 96.174% |
| Humana Inc. | 10.21 Billion USD | 99.051% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 89.77% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 98.371% |
| Masimo Corporation | 970 Million USD | 90.003% |
| McKesson Corporation | 5.47 Billion USD | 98.228% |
| Patterson Companies, Inc. | 762.94 Million USD | 87.29% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 98.194% |
| ResMed Inc. | 873.93 Million USD | 88.904% |
| Henry Schein, Inc. | 2.74 Billion USD | 96.462% |
| Teladoc Health, Inc. | 1.59 Billion USD | 93.91% |
| Universal Health Services, Inc. | 5.36 Billion USD | 98.193% |
| Veeva Systems Inc. | 55.77 Million USD | -73.856% |
| Baxter International Inc. | 14.36 Billion USD | 99.325% |
| Becton, Dickinson and Company | 15.87 Billion USD | 99.389% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -7.982% |
| Danaher Corporation | 19.35 Billion USD | 99.499% |
| Stryker Corporation | 12.99 Billion USD | 99.254% |
| Medtronic plc | 24.96 Billion USD | 99.612% |